Remi Gaston-Dreyfus - 31 Mar 2022 Form 4 Insider Report for Bionik Laboratories Corp.

Role
Director, 10%+ Owner
Signature
/s/ Remi Gaston-Dreyfus
Issuer symbol
BNKL on OTC
Transactions as of
31 Mar 2022
Net transactions value
+$739,926
Form type
4
Filing time
21 Jun 2022, 17:47:08 UTC
Previous filing
13 Dec 2021
Next filing
21 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNKL Common Stock, par value $0.001 per share Conversion of derivative security $739,926 +77,887 +5.1% $9.50* 1,616,840 31 Mar 2022 Shares held through GD Holdings and Lombard International Assurance SA F1
holding BNKL Common Stock, par value $0.001 per share 61,256 31 Mar 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effective as of March 31, 2022, an aggregate amount of $739,926 of principal and accrued interest in a convertible promissory note issued to GD Holdings converted in accordance with its terms into 77,887 shares of the Issuer's common stock.